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Dr Michael Costanza (Syracuse, NY): Gender differences in
vascular disease have been described for at least 20 years and
previous studies suggest that women fare poorly compared to men
with respect to timely diagnosis, treatment provided, and surgical
outcome. Whether this gender disparity still exists in the era of
endovascular therapy remains unclear.
Although this study showed a dramatic rise in endovascular
procedures for peripheral arterial disease [PAD], women did not
appear to benefit as much as men. Specifically, women underwent
fewer procedures, were more likely to require emergent hospital-
izations, and had a higher mortality and amputation rate. Studies
likes this on large data sets often raise as many questions as theyFirst, you acknowledge that your source data do not include
outpatient procedures. Do you have any estimate of how many
outpatient procedures for PAD are being performed? And since the
majority of claudicants are being treated electively, presumably as
outpatients, and your data set has emergent hospitalization rates of
80%, do you feel that your results can give us an accurate picture of
endovascular treatment for claudication?
Second, you showed that women hadmore frequent emergent
hospitalizations and unscheduled procedures; however, you also
point out that over the last few years, women actually had the lower
rate of admission for critical limb ischemia. At least on the surface
these seem to be contradictory findings. Is there a way that you can
reconcile these results?
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smallest difference in mortality between women and men and you
conclude that endovascular therapy holds the promise of being an
equalizer by eliminating gender differences. Unfortunately, this
promise has not been realized, at least not in the treatment of PAD,
and gender disparity persists. Do you think that the reason for this
is the failure of the medical community to educate women about
PAD and to detect it in women, or do you think the blame rests on
proceduralists like us who don’t use endovascular therapy in
women as aggressively as they do in men?
Dr Natalia Egorova: Question 1. Unfortunately, outpatient
surgery data are not available for all the states that we included in
the analysis, but they were available for New York State. In New
York State, approximately one-third of endovascular procedures
are done on an outpatient basis and less than 15% of claudicants are
treated as outpatients. So we think that our data depict the gender
difference in the management of patients with claudication accu-
rately. However, it will be very interesting to analyze gender
differences using outpatient data.
Question 2. Women were more frequently hospitalized emer-
gently for PAD-related diagnosis. So about 80% of PAD-related
hospitalizations were emergencies. We didn’t analyze in detail howmany procedures were performed emergently, but a very brief look
at these data showed approximately 50%. And again, the difference
between men and women were approximately the same.
Critical limb ischemia accounts only for 30% of PAD-emergent
hospitalizations. So women were more likely to be admitted emer-
gently, not because they have more critical limb ischemia than
men, but because they may have other emergent conditions, such
as infection, thrombosis, embolism, and other postoperative com-
plications.
Question 3. Endovascular treatment was offered almost in
equal proportion to men and women. And we showed in our
analysis some outcomes improved over time, such as gender dis-
parities in length of stay and mortality.
We agree with you that maybe women should be treated
more aggressively endovascularly, and that will lead to future
improvement in outcomes. However, we believe that the main
problem in disparity is that women with PAD are not recog-
nized early enough. Women do not optimize as well as men
before the procedure, and risk stratification in women can be
also improved. We also agree with you that raising public
awareness through education can improve outcomes in women
and eliminate the gender differences.
